TG11 Antibody ([Source 1]):
Type: IgG2b monoclonal antibody (mAb)
Target: Extracellular polysaccharide (EPS) antigens (20–250 kDa) secreted by Mucorales fungi.
Specificity: Does not cross-react with Aspergillus, Candida, or other clinically relevant fungi.
Application: Developed for rapid diagnosis of mucoromycosis via lateral-flow assays.
Research Significance: First antigen-specific test for detecting mucoromycosis biomarkers.
KLHL11 Antibody ([Sources 2, 5–7]):
Type: Autoantibody targeting intracellular Kelch-like protein 11 (KLHL11).
Association: Paraneoplastic encephalitis linked to testicular germ cell tumors (e.g., seminomas, teratomas).
Diagnostic Features:
| Clinical Feature | Details |
|---|---|
| Median Titer | Serum: 1:30,720; CSF: >1:640 |
| MRI Findings | Cerebellar atrophy, T2-hyperintensities |
| CSF Profile | Intrathecal IgG synthesis, unmatched oligoclonal bands (>8) |
| Co-occurring Antibodies | Ma2 (44%), NMDAR (22%) |
Immunopathology: T-cell–mediated neuronal injury, poor response to immunotherapy (58% stabilization rate).
Target: Galα1–3Galβ1–4GlcNAc (α-gal) glycan.
Germline Restriction: Heavy-chain gene IGHV3-7 encodes a conserved W33 motif in CDRH1.
Clinical Relevance: Linked to mammalian meat allergy, resistance to xenotransplantation, and infection.
While no "TGAL11" is listed, recent approvals include:
| Antibody Name | Target | Format | Indication |
|---|---|---|---|
| Retifanlimab | PD-1 | Humanized IgG4 | Merkel cell carcinoma (2024) |
| Faricimab | VEGF-A, Ang-2 | Bispecific IgG1 | Neovascular eye diseases |
Hypothesis 1: "TGAL11" may refer to TG11 (anti-Mucorales mAb) with a typographical error.
Hypothesis 2: The term could conflate features of KLHL11 (paraneoplastic autoantibody) and α-galactosyl antibodies.
Recommendation: Verify the compound’s nomenclature or context. If referring to KLHL11 or TG11, substantial research data are available (see tables above).
No peer-reviewed studies, patents, or clinical trials indexed in PubMed or PMC (as of March 2025) reference "TGAL11 Antibody."
Cross-referencing the Antibody Society’s therapeutic database ([Source 3]) also yielded no matches.
TGAL11 Antibody (product code: CSB-PA200772XA01OFG) is a polyclonal antibody developed against the TGAL11 protein from Oryza sativa subsp. japonica (rice). It is specifically raised in rabbits using recombinant TGAL11 protein as the immunogen and has been affinity-purified to enhance specificity. This antibody is designed exclusively for research applications and should not be used for diagnostic or therapeutic purposes. The target protein, TGAL11 (UniProt accession: Q2QXL0), is expressed in rice and belongs to a family of proteins involved in plant developmental processes .
TGAL11 Antibody should be stored at either -20°C or -80°C immediately upon receipt. It is critical to avoid repeated freeze-thaw cycles as these can compromise antibody functionality and affinity. The antibody is provided in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during long-term storage. For working solutions, store at 4°C for short-term use (1-2 weeks) and prepare fresh dilutions for optimal performance in experimental applications .
TGAL11 Antibody has been specifically tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications. These applications allow researchers to detect, quantify, and characterize the TGAL11 protein in rice samples. When employing this antibody in untested applications such as immunohistochemistry or immunofluorescence, researchers should conduct preliminary validation experiments with appropriate positive and negative controls to establish optimal working conditions .
Optimal working dilutions for TGAL11 Antibody vary by application and should be determined empirically for each experiment. Based on standard protocols for similar polyclonal antibodies in plant research, the following ranges can serve as starting points:
| Application | Recommended Dilution Range | Suggested Starting Dilution |
|---|---|---|
| ELISA | 1:1,000 - 1:10,000 | 1:5,000 |
| Western Blot | 1:500 - 1:2,000 | 1:1,000 |
| IHC* | 1:100 - 1:500 | 1:200 |
| IF* | 1:50 - 1:200 | 1:100 |
*Applications not officially validated; requires optimization
Note: These recommendations are based on general principles for polyclonal antibodies against plant proteins. Individual optimization is essential for achieving optimal signal-to-noise ratios.
When designing experiments with TGAL11 Antibody, include the following controls to ensure valid interpretation of results:
Positive control: Wild-type rice tissue samples known to express TGAL11 protein
Negative control: Either TGAL11 knockout/knockdown rice tissues or non-rice plant tissues
Secondary antibody control: Sample processed with secondary antibody only (omitting TGAL11 primary antibody)
Blocking peptide control: Pre-incubation of TGAL11 Antibody with its immunogenic peptide to confirm specificity
Inclusion of these controls helps distinguish between specific binding and background signals, supporting confident interpretation of experimental results.
Validating antibody specificity is crucial for obtaining reliable results. For TGAL11 Antibody, consider implementing these validation approaches:
Genetic models: Use CRISPR/Cas9-generated TGAL11 knockout or RNAi-mediated knockdown rice plants to confirm signal absence/reduction.
Multiple detection methods: Compare results across different techniques (e.g., Western blot and ELISA) to confirm consistent target recognition.
Recombinant protein competition: Pre-incubate the antibody with purified recombinant TGAL11 protein before application to samples. A specific antibody will show reduced or eliminated signal.
Mass spectrometry validation: After immunoprecipitation with TGAL11 Antibody, analyze pulled-down proteins using LC-MS/MS to confirm identity of the recognized protein.
Epitope mapping: Determine the specific regions of TGAL11 protein recognized by the antibody using peptide arrays or deletion mutants.
These approaches, while labor-intensive, provide comprehensive evidence for antibody specificity in plant-based research systems.
Effective protein extraction is critical for successful TGAL11 detection. The following protocol is recommended based on plant protein extraction principles:
Tissue collection and preparation:
Collect fresh rice tissue (leaves, roots, or other relevant tissues)
Flash-freeze in liquid nitrogen and grind to a fine powder using a pre-chilled mortar and pestle
Maintain frozen state throughout grinding to prevent protein degradation
Extraction buffer composition:
50 mM Tris-HCl (pH 7.5)
150 mM NaCl
1% Triton X-100 (or 0.1% SDS)
1 mM EDTA
10% glycerol
Protease inhibitor cocktail
1 mM DTT or 5 mM β-mercaptoethanol
1 mM PMSF (add fresh)
Extraction procedure:
Add extraction buffer to ground tissue (4 mL per gram)
Vortex thoroughly and incubate on ice for 30 minutes with periodic agitation
Centrifuge at 15,000 × g for 20 minutes at 4°C
Collect supernatant and determine protein concentration
Aliquot and store at -80°C
Different extraction buffers may be required depending on the subcellular localization of TGAL11 in rice cells. Optimization may be necessary for different tissue types or developmental stages.
TGAL11 Antibody can be employed in several techniques to investigate protein-protein interactions:
Co-immunoprecipitation (Co-IP):
Use TGAL11 Antibody coupled to protein A/G beads to pull down TGAL11 protein complexes
Identify interacting partners through Western blotting or mass spectrometry
Verify interactions through reciprocal Co-IP with antibodies against putative partners
Proximity Ligation Assay (PLA):
Utilize TGAL11 Antibody alongside antibodies against candidate interacting proteins
PLA signals indicate protein proximity within 40 nm, suggesting potential interaction
This technique is particularly valuable for visualizing interactions in situ within plant tissues
Immunofluorescence co-localization:
Perform dual immunolabeling with TGAL11 Antibody and antibodies against putative interactors
Analyze co-localization patterns using confocal microscopy and quantitative co-localization algorithms
FRET-based approaches:
Label TGAL11 Antibody with donor fluorophore and potential interactor antibody with acceptor fluorophore
Measure Förster Resonance Energy Transfer to detect molecular proximity
These methodologies require careful optimization of fixation, permeabilization, and antibody incubation conditions for plant tissues.
When encountering challenges with TGAL11 Antibody performance, consider these troubleshooting strategies:
| Issue | Potential Causes | Solutions |
|---|---|---|
| Weak or no signal | - Insufficient protein amount - Protein degradation - Inefficient transfer (WB) - Suboptimal antibody dilution | - Increase protein loading - Add fresh protease inhibitors - Optimize transfer conditions - Test different antibody concentrations |
| High background | - Insufficient blocking - Excessive antibody concentration - Cross-reactivity - Inadequate washing | - Increase blocking time/concentration - Dilute antibody further - Use alternative blocking agents - Increase wash duration/frequency |
| Multiple bands (WB) | - Protein degradation - Post-translational modifications - Cross-reactivity - Splice variants | - Use fresh samples with protease inhibitors - Verify with phosphatase treatment - Perform peptide competition - Validate with RNA expression data |
| Inconsistent results | - Sample variability - Antibody degradation - Protocol inconsistencies | - Standardize sample preparation - Aliquot antibody to avoid freeze-thaw - Follow standardized protocols |
For plant-specific issues, consider that cell wall components can interfere with antibody accessibility. Extended permeabilization steps or alternative fixation methods may improve results in histological applications.
Post-translational modifications (PTMs) can significantly impact antibody recognition of the TGAL11 protein. Common plant protein PTMs include phosphorylation, glycosylation, ubiquitination, and SUMOylation. Consider these aspects when working with TGAL11 Antibody:
Phosphorylation effects:
Phosphorylation may alter epitope structure, enhancing or inhibiting antibody binding
Compare results from samples treated with and without phosphatase inhibitors
For phosphorylation-specific detection, consider using phospho-specific antibodies if available
Glycosylation considerations:
Plant proteins often undergo glycosylation, which can mask epitopes
Enzymatic deglycosylation prior to analysis may improve detection if glycosylation interferes
Ubiquitination and SUMOylation:
These modifications can cause higher molecular weight bands in Western blots
Verify using deubiquitinating enzymes or through immunoprecipitation followed by ubiquitin blotting
Methods to distinguish PTM effects:
Parallel analysis of recombinant TGAL11 (lacking PTMs) and native protein
Treatment with specific enzymes that remove particular PTMs before analysis
Immunoprecipitation followed by mass spectrometry to identify specific modifications
Understanding the PTM status of TGAL11 in different experimental conditions can provide valuable insights into its regulation and function.
Assessing cross-reactivity with related TGAL family proteins is essential for accurate data interpretation. Implement these approaches to evaluate potential cross-reactivity:
Recombinant protein panel testing:
Express and purify various TGAL family proteins
Perform Western blot or ELISA analysis using identical protein amounts
Compare signal intensities to quantify relative cross-reactivity
Competitive binding assays:
Pre-incubate TGAL11 Antibody with purified recombinant related proteins
Measure residual binding to immobilized TGAL11 protein
Significant signal reduction indicates cross-reactivity
Epitope sequence analysis:
Compare sequence homology in potential epitope regions across TGAL family proteins
Identify unique vs. conserved regions that may contribute to cross-reactivity
Design blocking peptides based on shared regions to confirm cross-reactivity mechanisms
Genetic validation:
Test antibody reactivity in rice lines with specific TGAL family gene knockouts
Absence of signal in a TGAL11 knockout but presence in other TGAL knockouts confirms specificity
Documenting cross-reactivity profiles enhances experimental design and supports accurate interpretation of results involving TGAL family proteins.
TGAL11 Antibody enables investigation of protein-level responses to various environmental stresses in rice. Consider these experimental approaches:
Expression profiling across stress conditions:
Subject rice plants to different stresses (drought, salinity, temperature, pathogens)
Collect tissues at various time points during stress exposure
Analyze TGAL11 protein levels via Western blot or ELISA
Correlate protein changes with physiological responses and transcriptomic data
Subcellular localization changes during stress:
Perform immunolocalization studies using TGAL11 Antibody on tissues from stressed and control plants
Analyze potential relocalization under different stress conditions
Combine with organelle markers to identify specific compartments involved in response
Protein modification analysis:
Investigate stress-induced post-translational modifications of TGAL11
Use 2D gel electrophoresis followed by Western blotting to resolve modified forms
Combine with phospho-specific detection methods if phosphorylation is suspected
Protein-protein interaction networks during stress:
Perform co-immunoprecipitation experiments using TGAL11 Antibody in stressed vs. control conditions
Identify differential interaction partners using mass spectrometry
Map stress-responsive protein interaction networks
These approaches provide multi-dimensional insights into TGAL11's role in plant stress adaptation mechanisms.
For precise quantification of TGAL11 protein levels across experimental conditions, employ these methodologies:
Quantitative Western blotting:
Include recombinant TGAL11 protein standards at known concentrations
Use fluorescent secondary antibodies for broader linear detection range
Apply digital image analysis software with appropriate normalization to loading controls
Ensure analysis falls within the validated linear range of detection
| Sample Type | Recommended Loading Amount | Suggested Normalization Controls |
|---|---|---|
| Leaf tissue | 20-40 μg total protein | Actin, GAPDH, Tubulin |
| Root tissue | 30-50 μg total protein | Actin, Tubulin, UBQ10 |
| Callus | 15-30 μg total protein | Actin, GAPDH, UBQ10 |
Quantitative ELISA:
Develop a sandwich ELISA using TGAL11 Antibody as capture or detection antibody
Generate standard curves using purified recombinant TGAL11
Ensure sample concentrations fall within the linear range of the standard curve
Calculate absolute protein concentration based on standard curve interpolation
Capillary electrophoresis immunoassay:
Utilize automated capillary immunoassay systems for high-throughput analysis
Incorporate internal standards for normalization
Analyze multiple samples simultaneously for comparative studies
Immunohistochemical quantification:
Apply consistent image acquisition parameters across samples
Use fluorescence intensity measurements with appropriate background correction
Normalize to cell number or tissue area
Apply machine learning algorithms for automated quantification across tissue sections
These quantitative approaches support robust statistical analysis of TGAL11 expression patterns in diverse experimental contexts.
TGAL11 Antibody provides opportunities for comparative studies across plant species and developmental contexts:
Evolutionary conservation analysis:
Test cross-reactivity with TGAL11 orthologs in related grass species
Compare protein expression patterns across evolutionary distances
Correlate structural conservation with functional conservation
Map evolutionary changes in protein expression and localization patterns
Developmental profiling:
Track TGAL11 protein expression throughout rice development from seed to maturity
Analyze tissue-specific expression patterns using immunohistochemistry
Correlate protein expression with developmental transitions and environmental responses
Compare with transcriptomic data to identify post-transcriptional regulatory mechanisms
Functional genomics integration:
Combine antibody-based detection with CRISPR/Cas9 gene editing approaches
Generate knock-in reporter lines to complement antibody-based detection
Integrate protein-level data with genome-wide association studies
Correlate natural variation in protein expression with phenotypic traits
These approaches leverage TGAL11 Antibody as a tool for advancing fundamental understanding of plant biology across evolutionary and developmental contexts.
Multiplexing strategies enable simultaneous detection of TGAL11 alongside other proteins of interest:
Antibody compatibility assessment:
Ensure TGAL11 Antibody (rabbit polyclonal) is compatible with other primary antibodies (different host species)
Validate absence of cross-reactivity between secondary antibodies
Test for potential epitope masking when multiple antibodies bind nearby targets
Optimize antibody concentrations individually before combining
Sequential immunolabeling strategies:
Apply TGAL11 Antibody first, followed by complete detection
Strip or quench signals before applying subsequent antibodies
Document complete removal of initial signals before proceeding
Consider tyramide signal amplification for improved sensitivity and multicolor detection
Spectral considerations for fluorescence applications:
Select fluorophores with minimal spectral overlap
Perform single-color controls to establish spectral unmixing parameters
Consider brightness matching when designing multiplex panels
Include appropriate compensation controls
Validation of multiplex results:
Confirm findings with single-plex experiments in parallel
Use alternative detection methods to verify co-expression or co-localization
Apply quantitative colocalization analysis with appropriate statistical measures
Well-designed multiplex experiments maximize information yield while maintaining experimental rigor and reliability.